These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18829859)

  • 1. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
    Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
    Nagai N; Oike Y; Noda K; Urano T; Kubota Y; Ozawa Y; Shinoda H; Koto T; Shinoda K; Inoue M; Tsubota K; Yamashiro K; Suda T; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2925-31. PubMed ID: 16043867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of macrophage migration inhibitory factor in corneal neovascularization.
    Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
    Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
    Kurihara T; Ozawa Y; Shinoda K; Nagai N; Inoue M; Oike Y; Tsubota K; Ishida S; Okano H
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5545-52. PubMed ID: 17122147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.
    Moore JE; McMullen TC; Campbell IL; Rohan R; Kaji Y; Afshari NA; Usui T; Archer DB; Adamis AP
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2905-15. PubMed ID: 12202509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
    Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
    Dell S; Peters S; Müther P; Kociok N; Joussen AM
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.
    Lu P; Li L; Liu G; Baba T; Ishida Y; Nosaka M; Kondo T; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3516-26. PubMed ID: 22570350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis.
    Mizushima T; Sasaki M; Ando T; Wada T; Tanaka M; Okamoto Y; Ebi M; Hirata Y; Murakami K; Mizoshita T; Shimura T; Kubota E; Ogasawara N; Tanida S; Kataoka H; Kamiya T; Alexander JS; Joh T
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G255-66. PubMed ID: 19940029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L; Fan Y; Wang F; Gu Q; Xu X
    Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
    Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.
    Nakano A; Hattori Y; Aoki C; Jojima T; Kasai K
    Hypertens Res; 2009 Sep; 32(9):765-9. PubMed ID: 19590508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.